139 related articles for article (PubMed ID: 36410310)
1. Impact of cannabis use and its cessation on the dosage and the efficacy of antipsychotic drugs in in- and outpatients with schizophrenia taking medication: A systematic review and meta-analysis.
Rault O; Romeo B; Butlen-Ducuing F; Rari E; Benyamina A; Martelli C
J Psychiatr Res; 2022 Dec; 156():713-721. PubMed ID: 36410310
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
3. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Kishi T; Iwata N
CNS Drugs; 2013 Sep; 27(9):731-41. PubMed ID: 23812802
[TBL] [Abstract][Full Text] [Related]
5. Sertindole for schizophrenia.
Lewis R; Bagnall AM; Leitner M
Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001715. PubMed ID: 16034864
[TBL] [Abstract][Full Text] [Related]
6. Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):191-202. PubMed ID: 28219485
[TBL] [Abstract][Full Text] [Related]
7. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.
De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J
CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.
Correll CU; Rubio JM; Inczedy-Farkas G; Birnbaum ML; Kane JM; Leucht S
JAMA Psychiatry; 2017 Jul; 74(7):675-684. PubMed ID: 28514486
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.
Vermeulen J; van Rooijen G; Doedens P; Numminen E; van Tricht M; de Haan L
Psychol Med; 2017 Oct; 47(13):2217-2228. PubMed ID: 28397632
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis.
Foglia E; Schoeler T; Klamerus E; Morgan K; Bhattacharyya S
Psychol Med; 2017 Jul; 47(10):1691-1705. PubMed ID: 28179039
[TBL] [Abstract][Full Text] [Related]
12. Clozapine versus typical neuroleptic medication for schizophrenia.
Wahlbeck K; Cheine M; Essali MA
Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
[TBL] [Abstract][Full Text] [Related]
13. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
Smith RC; Leucht S; Davis JM
Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
[TBL] [Abstract][Full Text] [Related]
14. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
15. The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses.
Haddad PM; Correll CU
Ther Adv Psychopharmacol; 2018 Nov; 8(11):303-318. PubMed ID: 30344997
[TBL] [Abstract][Full Text] [Related]
16. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers?
Schaub M; Fanghaenel K; Senn C; Stohler R
Subst Use Misuse; 2008 Dec; 43(14):2045-52. PubMed ID: 19085437
[TBL] [Abstract][Full Text] [Related]
17. Pimozide for schizophrenia or related psychoses.
Mothi M; Sampson S
Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
[TBL] [Abstract][Full Text] [Related]
18. Prescribing Practice in Inpatients Versus Outpatients With Schizophrenia Initiating Treatment With Second-Generation Antipsychotics: A Naturalistic Follow-Up Study.
Edlinger M; Rettenbacher MA; Kemmler G; Biedermann F; Widschwendter CG; Fleischhacker WW; Hofer A
J Clin Psychopharmacol; 2016 Dec; 36(6):621-627. PubMed ID: 27662459
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan.
Kishi T; Ikuta T; Sakuma K; Okuya M; Iwata N
J Psychiatr Res; 2021 Jun; 138():444-452. PubMed ID: 33964682
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States.
Martin A; Bessonova L; Hughes R; Doane MJ; O'Sullivan AK; Snook K; Cichewicz A; Weiden PJ; Harvey PD
Adv Ther; 2022 Sep; 39(9):3933-3956. PubMed ID: 35844007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
